ReviewReview Article
Open Access

A review of the gastrointestinal, olfactory, and skin abnormalities in patients with Parkinson’s disease

Mohannad A. Almikhlafi
Neurosciences Journal January 2024, 29 (1) 4-9; DOI: https://doi.org/10.17712/nsj.2024.1.20230062

References

  1. 1.↵
    1. Almikhlafi MA,
    2. Karami MM,
    3. Jana A,
    4. Alqurashi TM,
    5. Majrashi M,
    6. Alghamdi BS, et al.
    Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders. Curr Neuropharmacol 2022.
  2. 2.↵
    1. Han MN,
    2. Finkelstein DI,
    3. McQuade RM,
    4. Diwakarla S
    . Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics. J Pers Med 2022; 12:
  3. 3.↵
    1. Pfeiffer RF
    . Gastrointestinal dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 2011; 17: 10–15.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lubomski M,
    2. Rushworth RL,
    3. Tisch S
    . Hospitalisation and comorbidities in Parkinson’s disease: a large Australian retrospective study. J Neurol Neurosurg Psychiatry 2015; 86: 324–330.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Navarre CB,
    2. Pugh D
    . Diseases of the gastrointestinal system. Sheep & Goat Medicine 2002: 69–105.
  6. 6.↵
    1. Vighi G,
    2. Marcucci F,
    3. Sensi L,
    4. Di Cara G,
    5. Frati F
    . Allergy and the gastrointestinal system. Clin Exp Immunol. 2008; 153: 3–6.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Barnham KJ,
    2. Masters CL,
    3. Bush AI
    . Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004; 3: 205–214.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Hansson O
    . Biomarkers for neurodegenerative diseases. Nat Med 2021; 27: 954–963.
    OpenUrl
  9. 9.↵
    1. Makaroff L,
    2. Gunn A,
    3. Gervasoni C,
    4. Richy F
    . Gastrointestinal disorders in Parkinson’s disease: prevalence and health outcomes in a US claims database. J Parkinsons Dis 2011; 1: 65–74.
    OpenUrl
  10. 10.↵
    1. Klingelhoefer L,
    2. Reichmann H
    . The Gut and Nonmotor Symptoms in Parkinson’s Disease. Int Rev Neurobiol 2017; 134: 787–809.
    OpenUrl
  11. 11.↵
    1. Bu LL,
    2. Huang KX,
    3. Zheng DZ,
    4. Lin DY,
    5. Chen Y,
    6. Jing XN, et al.
    Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study. Front Aging Neurosci 2020; 12: 575481.
    OpenUrl
  12. 12.↵
    1. Edwards LL,
    2. Quigley EM,
    3. Harned RK,
    4. Hofman R,
    5. Pfeiffer RF
    . Characterization of swallowing and defecation in Parkinson’s disease. Am J Gastroenterol 1994; 89: 15–25.
    OpenUrlPubMedWeb of Science
  13. 13.↵
    1. Gong S,
    2. Gao Y,
    3. Liu J,
    4. Li J,
    5. Tang X,
    6. Ran Q, et al.
    The prevalence and associated factors of dysphagia in Parkinson’s disease: A systematic review and meta-analysis. Front Neurol 2022; 13: 1000527.
    OpenUrl
  14. 14.↵
    1. Fasano A,
    2. Bove F,
    3. Gabrielli M,
    4. Petracca M,
    5. Zocco MA,
    6. Ragazzoni E, et al.
    The role of small intestinal bacterial overgrowth in Parkinson’s disease. Mov Disord 2013; 28: 1241–1249.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Gabrielli M,
    2. Bonazzi P,
    3. Scarpellini E,
    4. Bendia E,
    5. Lauritano EC,
    6. Fasano A, et al.
    Prevalence of small intestinal bacterial overgrowth in Parkinson’s disease. Mov Disord 2011; 26: 889–892.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Beckers M,
    2. Bloem BR,
    3. Verbeek MM
    . Mechanisms of peripheral levodopa resistance in Parkinson’s disease. NPJ Parkinsons Dis 2022; 8: 56.
    OpenUrl
  17. 17.↵
    1. Knudsen K,
    2. Szwebs M,
    3. Hansen AK,
    4. Borghammer P
    . Gastric emptying in Parkinson’s disease - A mini-review. Parkinsonism Relat Disord 2018; 55: 18–25.
    OpenUrl
  18. 18.↵
    1. Yao L,
    2. Liang W,
    3. Chen J,
    4. Wang Q,
    5. Huang X
    . Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Eur Neurol 2023; 86: 34–44.
    OpenUrl
  19. 19.↵
    1. Adams-Carr KL,
    2. Bestwick JP,
    3. Shribman S,
    4. Lees A,
    5. Schrag A,
    6. Noyce AJ
    . Constipation preceding Parkinson’s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2016; 87: 710–716.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Mathers SE,
    2. Kempster PA,
    3. Swash M,
    4. Lees AJ
    . Constipation and paradoxical puborectalis contraction in anismus and Parkinson’s disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry 1988; 51: 1503–1507.
    OpenUrlAbstract/FREE Full Text
  21. 21.
    1. Ishii T,
    2. Kinoshita KI,
    3. Muroi Y
    . Serotonin 5-HT(4) Receptor Agonists Improve Facilitation of Contextual Fear Extinction in an MPTP-Induced Mouse Model of Parkinson’s Disease. Int J Mol Sci 2019; 20: 5340
    OpenUrl
  22. 22.
    1. Freitas ME,
    2. Alqaraawi A,
    3. Lang AE,
    4. Liu LWC
    . Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism. Mov Disord Clin Pract 2018; 5: 218–220.
    OpenUrl
  23. 23.
    1. Singer C,
    2. Weiner WJ,
    3. Sanchez-Ramos JR
    . Autonomic dysfunction in men with Parkinson’s disease. Eur Neurol 1992; 32: 134–140.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Benayoun L,
    2. Pretolani M
    . [Airway remodeling in asthma: mechanisms and therapeutic perspectives]. Med Sci (Paris) 2003; 19: 319–326.
    OpenUrlPubMed
  25. 25.↵
    1. Alonso CCG,
    2. Silva FG,
    3. Costa LOP,
    4. Freitas S
    . Smell tests can discriminate Parkinson’s disease patients from healthy individuals: A meta-analysis. Clin Neurol Neurosurg. 2021; 211: 107024.
    OpenUrl
  26. 26.↵
    1. Janssen Daalen JM,
    2. Tosserams A,
    3. Mahlknecht P,
    4. Seppi K,
    5. Bloem BR,
    6. Darweesh SKL
    . Towards subgroup-specific risk estimates: A meta-analysis of longitudinal studies on olfactory dysfunction and risk of Parkinson’s disease. Parkinsonism Relat Disord 2021; 84: 155–163.
    OpenUrl
  27. 27.↵
    1. Kesayan T,
    2. Lamb DG,
    3. Falchook AD,
    4. Williamson JB,
    5. Salazar L,
    6. Malaty IA, et al.
    Abnormal tactile pressure perception in Parkinson’s disease. J Clin Exp Neuropsychol 2015; 37: 808–815.
    OpenUrl
  28. 28.↵
    1. Oppo V,
    2. Melis M,
    3. Melis M,
    4. Tomassini Barbarossa I,
    5. Cossu G
    . “Smelling and Tasting” Parkinson’s Disease: Using Senses to Improve the Knowledge of the Disease. Front Aging Neurosci 2020; 12: 43.
    OpenUrl
  29. 29.↵
    1. Lyu Z,
    2. Zheng S,
    3. Zhang X,
    4. Mai Y,
    5. Pan J,
    6. Hummel T, et al.
    Olfactory impairment as an early marker of Parkinson’s disease in REM sleep behaviour disorder: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2021; 92: 271–281.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Silva MME,
    2. Viveiros CP,
    3. Kotsifas NJE,
    4. Duarte A,
    5. Dib E,
    6. Mercer PBS, et al.
    Olfactory impairment in frontotemporal dementia: A systematic review and meta-analysis. Dement Neuropsychol 2019; 13: 154–161.
    OpenUrl
  31. 31.↵
    1. Tarakad A,
    2. Jankovic J
    . Anosmia and Ageusia in Parkinson’s Disease. Int Rev Neurobiol 2017; 133: 541–556.
    OpenUrl
  32. 32.↵
    1. Alonso CCG,
    2. Silva FG,
    3. Costa LOP,
    4. Freitas S
    . Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis. Expert Rev Neurother 2021; 21: 365–379.
    OpenUrl
  33. 33.↵
    1. Li J,
    2. Gu CZ,
    3. Su JB,
    4. Zhu LH,
    5. Zhou Y,
    6. Huang HY, et al.
    Changes in Olfactory Bulb Volume in Parkinson’s Disease: A Systematic Review and Meta-Analysis. PLoS One 2016; 11: e0149286.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Rahayel S,
    2. Frasnelli J,
    3. Joubert S
    . The effect of Alzheimer’s disease and Parkinson’s disease on olfaction: a meta-analysis. Behav Brain Res 2012; 231: 60–74.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Sorokowska A,
    2. Drechsler E,
    3. Karwowski M,
    4. Hummel T
    . Effects of olfactory training: a meta-analysis. Rhinology 2017; 55: 17–26.
    OpenUrlCrossRef
  36. 36.↵
    1. Sui X,
    2. Zhou C,
    3. Li J,
    4. Chen L,
    5. Yang X,
    6. Li F
    . Hyposmia as a Predictive Marker of Parkinson’s Disease: A Systematic Review and Meta-Analysis. Biomed Res Int 2019; 2019: 3753786.
    OpenUrl
  37. 37.↵
    1. Fang TC,
    2. Chang MH,
    3. Yang CP,
    4. Chen YH,
    5. Lin CH
    . The Association of Olfactory Dysfunction With Depression, Cognition, and Disease Severity in Parkinson’s Disease. Front Neurol 2021; 12: 779712.
    OpenUrl
  38. 38.↵
    1. Dabby R,
    2. Djaldetti R,
    3. Shahmurov M,
    4. Treves TA,
    5. Gabai B,
    6. Melamed E, et al.
    Skin biopsy for assessment of autonomic denervation in Parkinson’s disease. J Neural Transm (Vienna) 2006; 113: 1169–1176.
    OpenUrl
  39. 39.↵
    1. Fischer M,
    2. Gemende I,
    3. Marsch WC,
    4. Fischer PA
    . Skin function and skin disorders in Parkinson’s disease. J Neural Transm (Vienna) 2001; 108: 205–213.
    OpenUrl
  40. 40.↵
    1. Schestatsky P,
    2. Ehlers JA,
    3. Rieder CR,
    4. Gomes I
    . Evaluation of sympathetic skin response in Parkinson’s disease. Parkinsonism Relat Disord 2006; 12: 486–491.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Niemann N,
    2. Billnitzer A,
    3. Jankovic J
    . Parkinson’s disease and skin. Parkinsonism Relat Disord 2021; 82: 61–76.
    OpenUrl
  42. 42.↵
    1. Ravn AH,
    2. Thyssen JP,
    3. Egeberg A
    . Skin disorders in Parkinson’s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol 2017; 10: 87–92.
    OpenUrl
  43. 43.↵
    1. Ziemssen T,
    2. Reichmann H
    . Non-motor dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 2007; 13: 323–332.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Turkka JT,
    2. Myllyla VV
    . Sweating dysfunction in Parkinson’s disease. Eur Neurol 1987; 26: 1–7.
    OpenUrlPubMed
  45. 45.↵
    1. Ke JQ,
    2. Shao SM,
    3. Zheng YY,
    4. Fu FW,
    5. Zheng GQ,
    6. Liu CF
    . Sympathetic skin response and heart rate variability in predicting autonomic disorders in patients with Parkinson disease. Medicine (Baltimore) 2017; 96: e6523.
    OpenUrl
  46. 46.↵
    1. Onder H,
    2. Korkmaz B,
    3. Comoglu S
    . The rapid recovery of the sympathetic skin response in a patient with Parkinson’s disease with STN-DBS. Neurol Sci 2023; 44: 1077–1079.
    OpenUrl
  47. 47.↵
    1. Skorvanek M,
    2. Bhatia KP
    . The Skin and Parkinson’s Disease: Review of Clinical, Diagnostic, and Therapeutic Issues. Mov Disord Clin Pract 2017; 4: 21–31.
    OpenUrl
  48. 48.
    1. Tomic S,
    2. Kuric I,
    3. Kuric TG,
    4. Popovic Z,
    5. Kragujevic J,
    6. Zubonja TM, et al.
    Seborrheic Dermatitis Is Related to Motor Symptoms in Parkinson’s Disease. J Clin Neurol 2022; 18: 628–634.
    OpenUrl
  49. 49.
    1. Thiboutot D,
    2. Anderson R,
    3. Cook-Bolden F,
    4. Draelos Z,
    5. Gallo RL,
    6. Granstein RD, et al.
    Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2020; 82: 1501–1010.
    OpenUrl
  50. 50.↵
    1. Saunte DML,
    2. Gaitanis G,
    3. Hay RJ
    . Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Front Cell Infect Microbiol 2020; 10: 112.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section